BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
12.79
+0.60 (4.92%)
Aug 13, 2025, 2:45 PM - Market open
BrainsWay Market Cap
BrainsWay has a market cap or net worth of $230.73 million as of August 13, 2025. Its market cap has increased by 105.47% in one year.
Market Cap
230.73M
Enterprise Value
158.79M
1-Year Change
105.47%
Ranking
Category
Stock Price
$12.79
Market Cap Chart
Since September 3, 2013, BrainsWay's market cap has increased from $178.92M to $230.73M, an increase of 28.95%. That is a compound annual growth rate of 2.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 230.73M | 27.92% |
| Dec 31, 2024 | 180.37M | 70.88% |
| Dec 31, 2023 | 105.55M | 216.46% |
| Dec 29, 2022 | 33.35M | -73.96% |
| Dec 30, 2021 | 128.06M | 62.02% |
| Dec 31, 2020 | 79.04M | -26.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |